Kidney Amyloidosis: Updates on Pathogenesis and Therapeutic Frontiers

CE Cervantes, MG Atta - American Journal of Nephrology, 2024 - karger.com
Background: Amyloidosis includes a diverse group of rare diseases characterized by the
misfolding of native or mutant proteins, leading to extracellular accumulation in various …

Unveiling renal pathology's potential: exploring a rare subtype of amyloid–apolipoprotein CII amyloidosis in the youngest patient: a case report and literature review

Y Zuo, F Hanly, D Li, E Chavez, O Aljuboori… - Ultrastructural …, 2024 - Taylor & Francis
In this clinical case report, we present a rare subtype of amyloidosis, apolipoprotein CII (apo
CII), which was diagnosed through a renal biopsy and subsequently confirmed by identifying …

Kidney Transplant Outcomes in Amyloidosis: US National Database Study

J Yamauchi, D Raghavan, D Jweehan, S Oygen… - …, 2024 - journals.lww.com
Background. We aimed to assess contemporary transplant outcomes among kidney
recipients with amyloidosis, as the treatment and prognosis of amyloidosis have shown …

[HTML][HTML] Learning From Trials: Time to Look More Closely at the Kidneys in ATTR Amyloidosis?

L Obici, R Mussinelli, G Palladini - Cardio Oncology, 2024 - jacc.org
Systemic transthyretin amyloidosis (ATTR) is an emerging cause of cardiomyopathy and
heart failure, particularly in elderly people. Validation of noninvasive diagnostic approaches …

Novel Pyrrole Derivatives as Apolipoprotein L-1 Inhibitors for Treating Kidney Diseases and Sepsis

RW Sabnis - ACS Medicinal Chemistry Letters, 2023 - ACS Publications
Novel Pyrrole Derivatives as Apolipoprotein L-1 Inhibitors for Treating Kidney Diseases and
Sepsis Page 1 Novel Pyrrole Derivatives as Apolipoprotein L‑1 Inhibitors for Treating Kidney …

Renale Amyloidosen

J Gaedeke - Nephrologie aktuell, 2024 - thieme-connect.com
Die Amyloidosen sind eine Gruppe von seltenen Erkrankungen, die sich durch die Bildung
und Ablagerung von aberrant gefalteten Proteinen definieren. Grundsätzlich können sowohl …